Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors

Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors

The viral disease dengue is transmitted by the Aedes mosquito and is commonly seen to occur in the tropical and subtropical regions of the world. It is a growing public health concern. To date, other than supportive treatments, there are no specific antiviral treatments to combat the infection. Ther...

Full description

Bibliographic Details
Main Authors:	Anushka A. Poola, Prithvi S. Prabhu, T. P. Krishna Murthy, Manikanta Murahari, Swati Krishna, Mahesh Samantaray, Amutha Ramaswamy
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Molecular Biosciences
Subjects:	Dengue QSAR pharmacophore modeling docking molecular dynamics
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2023.1106128/full

Similar Items

Predictive Modeling of Antioxidant Coumarin Derivatives Using Multiple Approaches: Descriptor-Based QSAR, 3D-Pharmacophore Mapping, and HQSAR
by: Indrani MITRA, et al.
Published: (2016-09-01)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
by: Michael Kirstgen, et al.
Published: (2021-07-01)

Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity
by: Magdi E. A. Zaki, et al.
Published: (2021-08-01)

Applications of the Novel Quantitative Pharmacophore Activity Relationship Method QPhAR in Virtual Screening and Lead-Optimisation
by: Stefan Michael Kohlbacher, et al.
Published: (2022-09-01)

Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis
by: Syed Nasir Abbas Bukhari, et al.
Published: (2022-07-01)

Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B
by: Vijay H. Masand, et al.
Published: (2022-11-01)

Design of new molecules against cervical cancer using DFT, theoretical spectroscopy, 2D/3D-QSAR, molecular docking, pharmacophore and ADMET investigations
by: Said El Rhabori, et al.
Published: (2024-02-01)

Combretastatin A-4 based thiophene derivatives as antitumor agent: Development of structure activity correlation model using 3D-QSAR, pharmacophore and docking studies
by: Vijay K. Patel, et al.
Published: (2017-12-01)

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
by: Mahmoud Ganji, et al.
Published: (2023-02-01)

Pharmacophore, QSAR, molecular docking, molecular dynamics and ADMET study of trisubstituted benzimidazole derivatives as potent anti-tubercular agents
by: Anguraj Moulishankar, et al.
Published: (2024-06-01)

3D-QSAR study and development of pharmacophore for serotonin 5-HT2A receptors agonists
by: Radan Milica, et al.
Published: (2017-01-01)

Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors
by: Nathalie Moussa, et al.
Published: (2021-04-01)

QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human <i>N</i>-Myristoyltransferase (Hs-NMT) Inhibitors
by: Magdi E. A. Zaki, et al.
Published: (2021-03-01)

Hypouricemic effect of Grifola frondosa on hyperuricemic mice and virtual screening of bioactives by 3D QSAR pharmacophore modeling
by: Tianqiao Yong, et al.
Published: (2018-01-01)

Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer’s Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches
by: Oluwafemi Adeleke Ojo, et al.
Published: (2021-04-01)

Combined Pharmacophore Modeling, 3D-QSAR, Homology Modeling and Docking Studies on CYP11B1 Inhibitors
by: Rui Yu, et al.
Published: (2015-01-01)

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors
by: Vikas Kumar, et al.
Published: (2022-06-01)

Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study
by: Bikram Saha, et al.
Published: (2024-01-01)

Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
by: Ji-Xia Ren, et al.
Published: (2020-03-01)

Pharmacophore modeling and 3D quantitative structure-activity relationship analysis of febrifugine analogues as potent antimalarial agent
by: Debanjan Sen, et al.
Published: (2013-01-01)

The Integration of Pharmacophore-Based 3D-QSAR Modeling and Virtual Screening in Identification of Natural Product Inhibitors against SARS-CoV-2
by: Samira Norouzi, et al.
Published: (2021-11-01)

Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis
by: Magdi E. A. Zaki, et al.
Published: (2022-03-01)

Pharmacophore mapping studies on indolizine derivatives as 15-LOX inhibitors
by: Vikas Sharma, et al.
Published: (2015-06-01)

Novel indole derivatives as hepatitis C virus NS5B polymerase inhibitors: Pharmacophore modeling and 3D QSAR studies
by: G. Varun, et al.
Published: (2014-07-01)

Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures
by: Magdi E. A. Zaki, et al.
Published: (2022-06-01)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
by: Alina Kutlushina, et al.
Published: (2018-11-01)

QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors
by: Rahul D. Jawarkar, et al.
Published: (2024-06-01)

Combined Pharmacophore Modeling, 3D-QSAR, Molecular Docking and Molecular Dynamics Study on Indolyl-aryl-sulfone Derivatives as New HIV1 Inhibitors
by: Mebarka Ouassaf, et al.
Published: (2022-06-01)

Pharmacophore mapping: Prediction of BCR–ABL kinase inhibitory activity of α-benzylthio chalcones
by: Richa Bajaj, et al.
Published: (2014-06-01)

Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies
by: Maryam Foroozesh, et al.
Published: (2012-08-01)

Molecular modeling and analysis of the 3D pharmacophore structure of the selective PI3K-α inhibitors as antitumor agents
by: Jovanović Milan, et al.
Published: (2018-01-01)

Molecular docking and QSAR theoretical model for prediction of phthalazinone derivatives as new class of potent dengue virus inhibitors
by: Samuel Ndaghiya Adawara, et al.
Published: (2020-11-01)

Identification of PLK1-PBD Inhibitors from the Library of Marine Natural Products: 3D QSAR Pharmacophore, ADMET, Scaffold Hopping, Molecular Docking, and Molecular Dynamics Study
by: Nan Zhou, et al.
Published: (2024-02-01)

QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs
by: Yangxi Yu, et al.
Published: (2021-08-01)

Synthesis, Antibacterial Evaluation, and Computational Studies of a Diverse Set of Linezolid Conjugates
by: Riham M. Bokhtia, et al.
Published: (2022-02-01)

Targeting Dengue Virus NS-3 Helicase by Ligand based Pharmacophore Modeling and Structure based Virtual Screening
by: Sobia A. Halim, et al.
Published: (2017-10-01)

Pharmacophore modeling for the identification of small-molecule inhibitors of TACE
by: Liu, Li-Juan, et al.
Published: (2016)

3D-QSAR-based pharmacophore determination and design of novel DPP-4 inhibitors
by: Rogić Sanja, et al.
Published: (2022-01-01)

QSAR and docking based lead optimization of nitrogen heterocycles for enhanced prostaglandin EP2 receptor agonistic potency
by: Rahul D Jawarkar, et al.
Published: (2024-06-01)

Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of <i>Plasmodium falciparum</i> with Favourable ADME Profiles
by: Cecile Bieri, et al.
Published: (2023-04-01)